Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials

By sjmartinez • February 1, 2024

Kani R, Watanabe A, Miyamoto Y, Ejiri K, Iwagami M, Takagi H, Slipczuk L, Tsugawa Y, Aikawa T, Kuno T. Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2024 Jan 31:e031805. doi: 10.1161/JAHA.123.031805. Epub ahead of print. PMID: 38293914.

Tags: cardiovascular death or hospitalizations for HF, CKD, diabetes, General Internal Medicine, network meta‐analysis, Publications, SGLT2 inhibitors

A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide

Dao KT, Dhillon A, Uddin SS, Eppanapally S, Lai H. A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide. J[...]

Advancements in Spinal Cord Injury Rehabilitation

Eapen BC. Advancements in Spinal Cord Injury Rehabilitation. Phys Med Rehabil Clin N Am. 2025 Feb;36(1):xiii-xiv. doi: 10.1016/j.pmr.2024.09.002. Epub 2024 Oct 18. PMID: 39567042.

Higher-order disease interactions in multimorbidity measurement: marginal benefit over additive disease summation

Wei MY, Tseng CH, Kang AJ. Higher-order disease interactions in multimorbidity measurement: marginal benefit over additive disease summation. J Gerontol A Biol Sci Med Sci.[...]